Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
284 items
Emily Chew

Emily Chew named NIH distinguished investigator

A longstanding member of the NEI/NIH community, Emily Chew, M.D., has been promoted to the title of NIH Distinguished Investigator for her tireless and prolific work as a care provider and clinical trialist.
Andrew Bower

NEI postdoc to use research award to study cellular function with adaptive optics

The K99/R00 provides a runway for postdocs seeking to transition from mentored positions to tenure track positions at academic institutions in the U.S.
Eye Exam

Possible tool discovered to diagnose common contributor to vascular dementia

A research team has discovered that a non-invasive eye exam may be a possible tool for screening Black Americans and other people from underdiagnosed and high-risk populations for cerebral small vessel disease, a major contributor to cognitive impairment.
Nitin Verma

Filling the eye care gap down under

Nitin Verma visited NIH and shared his lifetime perspective on the delivery of vision care to underserved populations in the Australia/South Pacific region—roughly 50-million people scattered across vast stretches of land and ocean.

Short-term use of immunosuppressants not linked to cancer risk

Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research.

Cell therapy that repairs cornea damage with patient’s own stem cells achieves positive Phase I trial results

Cultivated autologous limbal epithelial cells (CALEC) procedure shown to be safe and feasible with early positive results of restored cornea surfaces or vision gains in four patients with severe chemical burns.
illustration showing axial elongation of the eye from myopia

Very low-dose atropine eye drops no better than placebo for slowing myopia progression

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years

Patients with specific types of lipids may be at higher risk of developing blinding eye disease

Scientists find association between lipid metabolism and glaucoma.
Retinal OCT showing fluid pocket in the macula

Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).
capsules

Multivitamin improves memory in older adults, study finds

Taking a daily multivitamin supplement can slow age-related memory decline, finds a large study led by researchers at Columbia University and Brigham and Women’s Hospital/Harvard.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248